Works about FORMOTEROL


Results: 461
    1
    2
    3
    4
    5
    6
    7

    Role of β-Adrenergic Receptors in Stress-Induced Cardiac Injury.

    Published in:
    Bulletin of Experimental Biology & Medicine, 2025, v. 178, n. 3, p. 311, doi. 10.1007/s10517-025-06327-9
    By:
    • Boshchenko, A. A.;
    • Kurbatov, B. K.;
    • Kilin, M.;
    • Maslov, L. N.;
    • Naryzhnaya, N. V.;
    • Saushkin, V. V.;
    • Zavadovsky, K. V.;
    • Stepanov, I. V.;
    • Gusakova, S. V.;
    • Birulina, Yu. G.;
    • Zaitseva, T. N.;
    • Smagliy, L. V.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT.

    Published in:
    Current Medical Research & Opinion, 2023, v. 39, n. 10, p. 1395, doi. 10.1080/03007995.2023.2247969
    By:
    • Stolz, Daiana;
    • Hermansson, Erik;
    • Ouwens, Mario;
    • Singh, Barinder;
    • Sharma, Akanksha;
    • Jackson, Dan;
    • Darken, Patrick;
    • Marshall, Jonathan;
    • Bowen, Karin;
    • Müllerová, Hana;
    • Alcázar Navarrete, Bernardino;
    • Russell, Richard;
    • Han, MeiLan K.;
    • Tansey-Dwyer, Deniz
    Publication type:
    Article
    17

    Bronchodilating effects of a new beclometasone dipropionate plus formoterol fumarate formulation via pressurized metered-dose inhaler in asthmatic children: a double-blind, randomized, cross-over clinical study.

    Published in:
    European Journal of Pediatrics, 2021, v. 180, n. 5, p. 1467, doi. 10.1007/s00431-020-03888-x
    By:
    • Pohunek, Petr;
    • Varoli, Guido;
    • Reznichenko, Yuriy;
    • Mokia-Serbina, Svetlana;
    • Brzostek, Jerzy;
    • Kostromina, Viktoriya;
    • Kaladze, Mykola;
    • Muraro, Annamaria;
    • Carzana, Elena;
    • Armani, Silvia;
    • Kaczmarek, Jadwiga
    Publication type:
    Article
    18
    19

    FDA Panel: Ban 2 Popular Asthma Drugs.

    Published in:
    JAMA: Journal of the American Medical Association, 2009, v. 301, n. 4, p. 365, doi. 10.1001/jama.2008.991
    By:
    • Kuehn, Bridget M.
    Publication type:
    Article
    20
    21
    22
    24
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Symbicort.

    Published in:
    Formulary, 2009, v. 44, n. 4, p. 101
    Publication type:
    Article
    36
    39
    40

    Identifying a nasal gene expression signature associated with hyperinflation and treatment response in severe COPD.

    Published in:
    Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-72551-0
    By:
    • Faiz, Alen;
    • Imkamp, Kai;
    • van der Wiel, Erica;
    • Boudewijn, Ilse M.;
    • Koppelman, Gerard H.;
    • Brandsma, Corry-Anke;
    • Kerstjens, Huib A. M.;
    • Timens, Wim;
    • Vroegop, Sebastiaan;
    • Pasma, Henk R.;
    • Boersma, Wim G.;
    • Wielders, Pascal;
    • van den Elshout, Frank;
    • Mansour, Khaled;
    • Steiling, Katrina;
    • Spira, Avrum;
    • Lenburg, Marc E.;
    • Heijink, Irene H.;
    • Postma, Dirkje S.;
    • van den Berge, Maarten
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50